4 Einträge |
Seite 1 / 1
![]() |
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with -Mutated Hepatocellular Carcinoma. |
Lim HY, Merle P, Weiss KH, Yau T, Ross P, Mazzaferro V, Blanc JF, Ma YT, Yen CJ, Kocsis J, Choo SP, Sukeepaisarnjaroen W, Gérolami R, Dufour JF, Gane EJ, Ryoo BY, Peck-Radosavljevic M, Dao T, Yeo W, Lamlertthon W, Thongsawat S, Teufel M, Roth K, Reis D, Childs BH, Krissel H, Llovet JM |
Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Jun 27. pii: 1078-0432.CCR-17-3588. doi: 10.1158/1078-0432.CCR-17-3588 |
PMID: 29950351 |
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation. |
Iavarone M, Invernizzi F, Czauderna C, Sanduzzi-Zamparelli M, Bhoori S, Amaddeo G, Manini MA, Fraile López M, Anders M, Pinter M, Blanco Rodríguez MJ, Romero Cristóbal M, Aballay Soteras G, Piñero F, Villadsen GE, Weinmann A, Crespo G, Mazzaferro V, Regnault H, De Giorgio M, González-Diéguez ML, Donato MF, Varela M, Wörns MA, Bruix J, Lampertico P, Reig M |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2019 Jul 31. doi: 10.1111/ajt.15551 |
PMID: 31365177 |
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. |
Schnitzbauer AA, Filmann N, Adam R, Bachellier P, Bechstein WO, Becker T, Bhoori S, Bilbao I, Brockmann J, Burra P, Chazoullières O, Cillo U, Colledan M, Duvoux C, Ganten TM, Gugenheim J, Heise M, van Hoek B, Jamieson N, de Jong KP, Klein CG, Klempnauer J, Kneteman N, Lerut J, Mäkisalo H, Mazzaferro V, Mirza DF, Nadalin S, Neuhaus P, Pageaux GP, Pinna AD, Pirenne J, Pratschke J, Powel J, Rentsch M, Rizell M, Rossi G, Rostaing L, Roy A, Scholz T, Settmacher U, Soliman T, Strasser S, Söderdahl G, Troisi RI, Turrión VS, Schlitt HJ, Geissler EK |
Annals of surgery. 2020 Sep 3. doi: 10.1097/SLA.0000000000004280 |
PMID: 32889867 |
Regorafenib efficacy after sorafenib in patients with recurrent HCC after liver transplantation: a retrospective study. |
Iavarone M, Invernizzi F, Ivanics T, Mazza S, Zavaglia C, Sanduzzi-Zamparelli M, Fraile-López M, Czauderna C, Di Costanzo G, Bhoori S, Pinter M, Manini MA, Amaddeo G, Yunquera AF, Piñero F, Blanco Rodríguez MJ, Anders M, Aballay Soteras G, Villadsen GE, Yoon PD, Cesarini L, Díaz-González Á, González-Diéguez ML, Tortora R, Weinmann A, Mazzaferro V, Romero Cristóbal M, Crespo G, Regnault H, De Giorgio M, Varela M, Prince R, Scuddeler L, Donato MF, Wörns MA, Bruix J, Sapisochin G, Lampertico P, Reig M |
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2021 Aug 13. doi: 10.1002/lt.26264 |
PMID: 34388851 |
4 Einträge |
Seite 1 / 1
![]() |